IP Library Granted Patent US 10,987,297
Granted Patent B2
US 10,987,297 · App. 16/072,261 · Granted Apr 27, 2021

Cosmetic agent formed by galactomannans obtained from

Inventor: Jean Paufique (Objat, FR)
Assignee: SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE
A61K8/737A61K8/73A61K8/9717A61K8/9789A61K8/9794A61K9/0014A61K36/04A61K36/48A61P39/00A61Q17/00A61Q19/08A61K2800/95
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,987,297
App. No.
16/072,261
Granted
Apr 27, 2021
Kind
B2
Abstract

A cosmetic or dermocosmetic agent consisting of galactomannans with molecular masses in a range from 1 to 150 kDa obtained from Caesalpinia spinose and cross-linked sulfated galactans with molar masses in a range from 1 to 150 kDa obtained from Kappaphycus alvarezii . Non-therapeutic cosmetic methods in which the agent is applied on the skin in order to tens the skin and/or to form a film on the skin.

Claims (26)

1. A cosmetic or dermocosmetic agent consisting of galactomannans obtained from Caesalpinia spinosa with average molar masses of between 5 and 30 kDa, and cross-linked sulfated galactans obtained from Kappaphycus alvarezii with molar masses of between 5 and 25 kDa and cross-linked with an ionic cross-linking agent, wherein the galactomannans and cross-linked sulfated galactans are present in an amount effective to produce a film-forming effect ensuring a tensor effect reducing the skin pores and reducing wrinkles and fine lines, and a skin-protector effect.

2. The cosmetic or dermocosmetic agent according to claim 1 , characterized in that the galactomannans obtained from Caesalpinia spinosa have an average molar mass of between 8 and 25 kDa, and the cross-linked sulfated galactans obtained from Kappaphycus alvarezii have an average molar mass of between 8 and 20 kDa.

3. The cosmetic or dermocosmetic agent according to claim 1 , characterized in that the galactomannans are obtained by hydrolysis of galactomannans of Caesalpinia spinosa.

4. The cosmetic or dermocosmetic agent according to claim 1 , characterized in that the cross-linked sulfated galactans are obtained by hydrolysis of sulfated galactans of Kappaphycus alvarezii.

5. The cosmetic or dermocosmetic agent according to claim 1 , characterized in that it consists of:

60 to 90% galactomannans, and

10 to 40% cross-linked sulfated galactans,

the percentages being given as mass/mass.

6. The cosmetic or dermocosmetic agent according to claim 1 , characterized in that it consists of:

70 to 90% galactomannans, and

10 to 30% cross-linked sulfated galactans,

the percentages being given as mass/mass.

7. The cosmetic or dermocosmetic agent according to claim 1 , characterized in that the galactomannans and cross-linked sulfated galactans together form an interpenetrated network.

8. A cosmetic or dermocosmetic composition suitable for a topical application onto human skin and comprising at least 0.1% of the agent according to claim 1 .

9. A cosmetic or dermocosmetic method for improving a condition of skin, the method comprising applying onto the skin the cosmetic composition of claim 8 .

10. The cosmetic or dermocosmetic method according to claim 9 , wherein the application of the agent improves the radiance of the skin.

11. The cosmetic or dermocosmetic method according to claim 10 , wherein the application of the agent combats skin ageing.

12. A method for tensing skin and/or forming a film on skin, the method comprising applying on the skin the cosmetic or dermocosmetic agent of claim 1 , and thereby tensing the skin and/or forming the film on the skin.

13. A method for protecting skin, the method comprising applying on the skin the cosmetic or dermocosmetic agent of claim 1 , and thereby protecting the skin.

14. A method for protecting skin against penetration of toxic molecules, the method comprising applying on the skin the cosmetic or dermocosmetic agent of claim 1 , and thereby protecting the skin against the penetration of toxic molecules.

15. A method for protecting skin against bacterial adhesion of pathogens, the method comprising applying on the skin the cosmetic or dermocosmetic agent of claim 1 , and thereby protecting the skin against the penetration of toxic molecules.

16. A method for improving a barrier effect of skin, the method comprising applying on the skin the cosmetic or dermocosmetic agent of claim 1 , and thereby improving the barrier effect of the skin.

17. A method for improving radiance of skin and/or smoothing a microrelief of skin and/or smoothing wrinkles, the method comprising applying on the skin the cosmetic or dermocosmetic agent of claim 1 , and thereby improving the radiance of the skin.

18. A method for combating skin ageing, the method comprising applying on the skin the cosmetic or dermocosmetic agent of claim 1 , and thereby combating skin ageing.

19. A method for improving a make-up hold and/or improving dispersion of pigments in cosmetic formulations, the method comprising applying on the skin the cosmetic or dermocosmetic agent of claim 1 , and thereby improving the make-up hold and/or improving the dispersion of pigments in cosmetic formulations.

20. A method for producing a second skin and producing a beauty booster effect, the method comprising applying on the skin the cosmetic or dermocosmetic agent of claim 1 , and thereby producing the second skin and producing the beauty booster effect.

Assignments (2)
CHANGE OF ADDRESS Recorded Jan 28, 2025
From: SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE
To: SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE
Reel/Frame 070028/0334 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2018
From: PAUFIQUE, JEAN
To: SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE
Reel/Frame 047697/0775 →
Priority Claims (1)
FR 1650741 · Jan 29, 2016 · national
Continuity (1)
Related Publication 20190070093A1 · Mar 7, 2019